Systemic bevacizumab for retinal angiomatous proliferation associated with retinal pigment epithelial detachment

European Journal of Ophthalmology

Volumn 17, Issue 6, 2007, Pages 987-991

  Abi Ayad, N ^a   Mauget Faÿsse, Martine ^b   Amara Allieu, S ^c   Ardisson, P ^d  

^a CROIX ROUSSE HOSPITAL   (France)

^b Rabelais Ophthalmologic Center   (France)

^c Department of Urology   (France)

^d Center of La Sauvegarde Consultations   (France)

Author keywords

Optical coherence tomography; Pigment epithelial detachment; Systemic bevacizumab

Indexed keywords

BEVACIZUMAB;

AGED; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTERVENTION STUDY; INTRAOCULAR HYPERTENSION; OFF LABEL DRUG USE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA EXUDATE; RETINA NEOVASCULARIZATION; RETINAL ANGIOMATOUS PROLIFERATION; RISK FACTOR; SYSTEMIC THERAPY; VASCULAR LESION;

EID: 39349102233     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700621     Document Type: Article

References (9)

1. Yannuzzi LA, Negrao S, Lida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21: 416-34.
2. Bottoni F, Massacesi A, Cigala M, et al. Treatment of retinal angiomatous proliferation in age-macular degeneration. Arch Ophthalmol 2005; 123: 1644-50.
3. Freund KB, Klais CM, Eandi CM, et al. Sequenced combined intravitreal triamcinolone and indocyanine angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 2006; 124: 487-92.
4. Michels S, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 2005; 112: 1035-47.
5. Schoeppner G, Chuang EL, Bird AC. The risk of fellow eye visual loss with unilateral retinal pigment epithelial tears. Am J Ophthalmol 1989; 108: 683-5.
6. Shah Chirag P, Hsu J, Garg Sunir J, et al. Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 2006; 142: 1070-1.
7. Spandau UHM, Jonas JB. Retinal pigment epithelial tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 2006; 142: 1068-70.
8. Moshfeghi AA, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration, twenty-four-week results of an uncontrolled open-label clinical study. Ophthalmology 2006; 113: 2002-11.
9. Bolz M, Michels S, Geitzenauer W, et al. Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment. Br J Ophthalmol 2007; 91: 785-9.